FCM
Frontier Capital Management Portfolio holdings
AUM
$10.8B
1-Year Return
32.36%
This Quarter Return
-7.22%
1 Year Return
+32.36%
3 Year Return
+147.77%
5 Year Return
+285.35%
10 Year Return
+891.74%
AUM
$9.15B
AUM Growth
-$1.38B
(-13%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
307
New
22
Increased
97
Reduced
164
Closed
24
Top Buys
| 1 |
Dolby
DLB
|
$72.1M |
| 2 |
Allegro MicroSystems
ALGM
|
$70.8M |
| 3 |
AMTM
Amentum Holdings, Inc.
AMTM
|
$65.1M |
| 4 |
Cheniere Energy
LNG
|
$55.3M |
| 5 |
Confluent
CFLT
|
$33.2M |
Top Sells
| 1 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$121M |
| 2 |
Palantir
PLTR
|
$76.8M |
| 3 |
Natera
NTRA
|
$62.5M |
| 4 |
Coinbase
COIN
|
$54.2M |
| 5 |
BorgWarner
BWA
|
$54.1M |
Sector Composition
| 1 | Technology | 24.4% |
| 2 | Industrials | 21.22% |
| 3 | Healthcare | 13.37% |
| 4 | Consumer Discretionary | 12.85% |
| 5 | Financials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Revvity
RVTY
$10.1B
| $5.16M | 0.06% |
48,762
-1,516
| -3% | -$160K |
|
252
Planet Labs
PL
$1.98B
| $5.08M | 0.06% |
1,503,074
-47,148
| -3% | -$159K |
|
253
Rogers Corp
ROG
$1.43B
| $5.07M | 0.06% |
75,133
-2,299
| -3% | -$155K |
|
254
Axsome Therapeutics
AXSM
$6.25B
| $5.05M | 0.06% |
43,261
-9,507
| -18% | -$1.11M |
|
255
Jazz Pharmaceuticals
JAZZ
$7.86B
| $4.94M | 0.05% |
39,786
+4,784
| +14% | +$594K |
|
256
TPG
TPG
$8.64B
| $4.8M | 0.05% |
101,204
-3,118
| -3% | -$148K |
|
257
Acadia Healthcare
ACHC
$2.19B
| $4.74M | 0.05% |
156,418
+32,527
| +26% | +$986K |
|
258
Parsons
PSN
$8.08B
| $4.52M | 0.05% |
+76,383
| New | +$4.52M |
|
259
International Seaways
INSW
$2.31B
| $4.37M | 0.05% |
131,761
+114,638
| +669% | +$3.81M |
|
260
Apogee Therapeutics
APGE
$2.26B
| $4.07M | 0.04% |
108,817
-63,894
| -37% | -$2.39M |
|
261
Magnite
MGNI
$3.54B
| $3.94M | 0.04% |
345,374
-301,309
| -47% | -$3.44M |
|
|
BPMC
262
DELISTED
Blueprint Medicines
BPMC
| $3.8M | 0.04% |
42,984
-62,146
| -59% | -$5.5M |
|
263
Teradyne
TER
$19.1B
| $3.75M | 0.04% |
45,416
+6,177
| +16% | +$510K |
|
264
Kymera Therapeutics
KYMR
$3.11B
| $3.61M | 0.04% |
131,963
-18,209
| -12% | -$498K |
|
265
DocuSign
DOCU
$16.1B
| $3.54M | 0.04% |
+43,550
| New | +$3.54M |
|
266
Amphastar Pharmaceuticals
AMPH
$1.37B
| $3.47M | 0.04% |
119,628
-3,732
| -3% | -$108K |
|
267
Sarepta Therapeutics
SRPT
$1.96B
| $3.41M | 0.04% |
53,443
+17,881
| +50% | +$1.14M |
|
268
Aspen Aerogels
ASPN
$544M
| $3.26M | 0.04% |
510,136
-15,602
| -3% | -$99.7K |
|
269
Helios Technologies
HLIO
$1.84B
| $3.24M | 0.04% |
101,032
-79,858
| -44% | -$2.56M |
|
270
Revolution Medicines
RVMD
$7.57B
| $3.24M | 0.04% |
+91,611
| New | +$3.24M |
|
271
FTAI Infrastructure
FIP
$481M
| $3.14M | 0.03% |
692,367
+298,516
| +76% | +$1.35M |
|
272
Dyne Therapeutics
DYN
$2.02B
| $3.03M | 0.03% |
289,603
-8,449
| -3% | -$88.4K |
|
273
UiPath
PATH
$6.15B
| $1.75M | 0.02% |
170,045
+91,775
| +117% | +$945K |
|
274
Enovix
ENVX
$1.81B
| $702K | 0.01% |
109,329
-247,804
| -69% | -$1.59M |
|
275
NiSource
NI
$19B
| $548K | 0.01% |
13,680
+186
| +1% | +$7.46K |
|